Skip to main content
. Author manuscript; available in PMC: 2009 May 22.
Published in final edited form as: Int J Pharm. 2008 Jan 17;356(1-2):345–350. doi: 10.1016/j.ijpharm.2008.01.014

Table 2.

Particle size of SSM containing VIP, GLP-1 and GIP before and after freeze drying.

Particle size (nm)*

Peptideb before FDa after FDa
VIP 12.6±2.9 12.8±2.8
GLP-1 12.8±2.7 13.2±2.4
GIP 12.5±3.6 12.8±2.8
*

For all peptides, comparison before and after FD were not statistically significant with p > 0.05.

a

FD, freeze drying

b

peptide (67 μM) - SSM at lipid concentration of 10 mM

HHS Vulnerability Disclosure